Latest Strategic Partnership News

LTR Pharma has announced that its erectile dysfunction treatment SPONTAN now boasts an 18-month shelf life, surpassing commercial standards and paving the way for international market growth.

Accent Group reported a modest 0.8% increase in FY2025 total sales to $1.62 billion, while profits dipped slightly. The company is advancing its store expansion and brand portfolio, targeting strong EBIT growth in FY26 despite startup costs.

Accent Group Limited reported a modest revenue increase but a 3.1% decline in net profit for FY25 amid a tough retail environment. The company announced a strategic partnership with Frasers Group to launch Sports Direct in Australia and New Zealand, signaling a new growth avenue.

BCI Minerals has transitioned to full-scale operations at its Mardie Salt Project, marking a pivotal moment with strong construction progress, secured financing, and binding offtake agreements. The company remains on track for first salt shipment by late 2026.

Latitude Group Holdings reports a remarkable 341% increase in statutory profit for 1H25, driven by record receivables and strategic partnerships. The company’s strong balance sheet and AI investments set the stage for sustained growth.

Cogstate Limited has reported a landmark FY25 with revenue up 22% and net profit before tax nearly doubling, driven by a surge in clinical trials contracts and strategic innovation. The company also declared its maiden fully franked dividend and outlined ambitious growth plans including AI product launches and an expanding Medidata partnership.

BrainChip Holdings reports a significant revenue surge and reduced losses in H1 2025, underpinned by new contracts, strategic collaborations, and an expanded funding agreement.

Wrkr Ltd reported a 10.8% revenue increase to $10.63 million and narrowed its net loss to $2.62 million for FY2025, while securing $15 million in fresh capital to accelerate growth amid upcoming PayDay Super reforms.

Atomo Diagnostics reports a significant expansion in its supply agreement with Lumos for the Pascal test cassette, tied to the promising CLIA waiver status of the FebriDx test in the US. This deal could nearly double Atomo’s revenues over the next three years.

RooLife Group Ltd (ASX, RLG) has launched its proprietary RLG Coffee brand in China, tapping into a rapidly expanding market with early sales exceeding $110,000 in the first month. Strategic partnerships and a recent supply deal position RLG for broader growth in the country’s evolving consumer landscape.

Tinybeans Group Ltd reported a significant reduction in losses and a 12% rise in subscription revenue for FY25, driven by a strategic pivot away from advertising. The company’s restructuring efforts have improved cash flow and positioned it for sustainable growth.

NAOS Ex-50 Opportunities Company Limited (ASX, NAC) reported a strong turnaround with a $7.55 million profit after tax for FY25 and a 28.9% portfolio return, declaring a 1.5 cent per share dividend. The company’s focused investments in emerging Australian and New Zealand companies underpin its robust performance and disciplined capital management.